Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Int Immunopharmacol 116:109772
We are targeting a first approval in 2028 from a portfolio that includes ultra-long-acting peptides with the potential, if successful, developed and approved for competitive efficacy and tolerability with a differentiated monthly maintenance dosing schedule
The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles
, 2021, vol
This isnt optional for your health
US$ 20.59
US$ 20.26
US$ 20.18
US$ 22.70
US$ 20.07
US$ 27.42
US$ 21.55
US$ 25.87
